Furthermore, β-catenin and Frizzled Class Receptor 4 (FZD4) are overexpressed in human bladder cancer, and Wnt/β-catenin signaling is activated by FZD4 stimulation, contributing to tumor progression. Here, FZD4 is linked to urinary bladder carcinoma.